Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Shock. 2013 Mar;39(3):286–292. doi: 10.1097/SHK.0b013e318282c9a1

Table 1.

Administration of TAT-SNAP-23 reduced CD18 plasma membrane expression in BAL cells.
CD18MCF (mean ± SEM) N=number of rats
Control 305 ± 37** 5
IC-ALI 611 ± 20 7
TAT-SNAP-23-IC-ALI 562 ± 16* 9
TAT-Control-IC-ALI 619 ± 12 9
*

p<0.05 compared to TAT-Control;

**

p<0.001 compared to IC-ALI